M. Teshome

Identification of Youthful Neurocognitive Trajectories in Adults Aging with HIV: A Latent Growth Mixture Model

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2021, AIDS and Behavior.

11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder.

A. Fagan, J. Morris, D. Holtzman, 2012, Archives of neurology.

Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy

F. Vaida, C. Fennema-Notestine, R. Heaton, 2017, The Journal of infectious diseases.

Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia

D. Clifford, S. Evans, G. Zenebe, 2011, Journal of NeuroVirology.

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease

A. Fagan, A. Shah, J. Morris, 2009, Neurology.

Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB

A. Fagan, M. Mintun, D. Holtzman, 2010, Neurology.

Chapter 19 – Primary neurological manifestation of HIV/AIDS

D. Clifford, M. Teshome, 2012 .

Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Seven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.

B. Dobkin, K. Marder, J. Long, 2020, JAMA neurology.

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease

A. Fagan, D. Holtzman, J. Kauwe, 2009, Neurology.

Etravirine in CSF is highly protein bound.

Michael J. Taylor, F. Vaida, C. Fennema-Notestine, 2013, The Journal of antimicrobial chemotherapy.